Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Marques

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
The Lancet. Infectious Diseases|August 15, 2024
Chikungunya vaccine VLA1553 induces sustained protective antibody concentrationsErnesto T A Marques, Rafael Dhalia
Lancet (London, England)|December 9, 2017
Tradition and innovation in development of a Zika vaccineErnesto T A Marques, Donald S Burke
The Lancet. Infectious Diseases|December 11, 2025
Chikungunya adolescent vaccination and the distinct risk-benefit landscapesErnesto T A Marques, Simon Barratt-Boyes
Mbio|September 5, 2019
Complex Scenario of Homotypic and Heterotypic Zika Virus Immune EnhancementErnesto T A Marques, Jan Felix Drexler
Lancet (London, England)|April 19, 2025
Safety and immunogenicity of a virus-like particle Chikungunya virus vaccineErnesto T A Marques, Donald S Burke
The Lancet. Infectious Diseases|May 21, 2021
Zika vaccines: can we solve one problem without creating another one?Priscila M S Castanha, Ernesto T A Marques
Plos Computational Biology|July 26, 2006
From functional genomics to functional immunomics: new challenges, old problems, big rewardsUlisses M Braga-Neto, Ernesto T A Marques
Current Topics in Microbiology and Immunology|June 5, 2025
T Cell Responses During Dengue InfectionLuciana Barros de Arruda, Ernesto T A Marques
Viruses|December 3, 2020
A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine DevelopmentPriscila M S Castanha, Ernesto T A Marques
The Lancet. Infectious Diseases|July 4, 2020
Vaccine development during global epidemics: the Zika experiencePriscila M S Castanha, Ernesto T A Marques
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
The Lancet. Infectious Diseases|August 15, 2024
Chikungunya vaccine VLA1553 induces sustained protective antibody concentrationsErnesto T A Marques, Rafael Dhalia
Lancet (London, England)|December 9, 2017
Tradition and innovation in development of a Zika vaccineErnesto T A Marques, Donald S Burke
The Lancet. Infectious Diseases|December 11, 2025
Chikungunya adolescent vaccination and the distinct risk-benefit landscapesErnesto T A Marques, Simon Barratt-Boyes
Mbio|September 5, 2019
Complex Scenario of Homotypic and Heterotypic Zika Virus Immune EnhancementErnesto T A Marques, Jan Felix Drexler
Lancet (London, England)|April 19, 2025
Safety and immunogenicity of a virus-like particle Chikungunya virus vaccineErnesto T A Marques, Donald S Burke
The Lancet. Infectious Diseases|May 21, 2021
Zika vaccines: can we solve one problem without creating another one?Priscila M S Castanha, Ernesto T A Marques
Plos Computational Biology|July 26, 2006
From functional genomics to functional immunomics: new challenges, old problems, big rewardsUlisses M Braga-Neto, Ernesto T A Marques
Current Topics in Microbiology and Immunology|June 5, 2025
T Cell Responses During Dengue InfectionLuciana Barros de Arruda, Ernesto T A Marques
Viruses|December 3, 2020
A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine DevelopmentPriscila M S Castanha, Ernesto T A Marques
The Lancet. Infectious Diseases|July 4, 2020
Vaccine development during global epidemics: the Zika experiencePriscila M S Castanha, Ernesto T A Marques
Pageof 15